Differential coexpression analysis using microarray data and its application to human cancer
TL;DR: A model for finding differential coexpression from microarrays is introduced and its biological validity with respect to cancer is tested and it is shown that this model would serve as a novel method for analyzing microarray beyond the specific implications for cancer.
read more
Abstract: Motivation: Microarrays have been used to identify differential expression of individual genes or cluster genes that are coexpressed over various conditions. However, alteration in coexpression relationships has not been studied. Here we introduce a model for finding differential coexpression from microarrays and test its biological validity with respect to cancer.
Results: We collected 10 published gene expression datasets from cancers of 13 different tissues and constructed 2 distinct coexpression networks: a tumor network and normal network. Comparison of the two networks showed that cancer affected many coexpression relationships. Functional changes such as alteration in energy metabolism, promotion of cell growth and enhanced immune activity were accompanied with coexpression changes. Coregulation of collagen genes that may control invasion and metastatic spread of tumor cells was also found. Cluster analysis in the tumor network identified groups of highly interconnected genes related to ribosomal protein synthesis, the cell cycle and antigen presentation. Metallothionein expression was also found to be clustered, which may play a role in apoptosis control in tumor cells. Our results show that this model would serve as a novel method for analyzing microarrays beyond the specific implications for cancer.
Supplementary information: Supplementary data are available at Bioinformatics online.
Contact: [email protected]
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders
TL;DR: This Review discusses how high-throughput molecular, integrative and network approaches inform disease biology by placing human genetics in a molecular systems and neurobiological context and provides a framework for interpreting network biology studies and leveraging big genomics data sets in neurobiology.
From ‘differential expression’ to ‘differential networking’ – identification of dysfunctional regulatory networks in diseases
TL;DR: This review describes the shift from differential gene expression to differential networking and outlines how this shift will affect the study of the genetic basis of disease.
433
Toward the dynamic interactome: it's about time
TL;DR: The beginnings of a new subfield within computational biology, one focused on the global inference and analysis of the dynamic interactome, are reviewed, which promises to be a major step forward in the ability to model and reason about cellular function and behavior.
295
Network topology reveals high connectance levels and few key microbial genera within soils
Manoeli Lupatini,Afnan Khalil Ahmad Suleiman,Rodrigo Josemar Seminoti Jacques,Zaida Inês Antoniolli,Adão de Siqueira Ferreira,Eiko E. Kuramae,Luiz Fernando Wurdig Roesch +6 more
TL;DR: Using correlation network analysis, soil bacterial genera that presented important microbial associations within the soil community were identified and might represent a step forward in microbial ecology beyond the conventional studies of microbial richness and abundance.
References
Gene Ontology: tool for the unification of biology
M Ashburner,Catherine A. Ball,Judith A. Blake,David Botstein,Heather Butler,J. M. Cherry,Allan Peter Davis,Kara Dolinski,Selina S. Dwight,J.T. Eppig,Midori A. Harris,David P. Hill,Laurie Issel-Tarver,Andrew Kasarskis,Suzanna E. Lewis,John C. Matese,Joel E. Richardson,M. Ringwald,Gerald M. Rubin,Gavin Sherlock +19 more
TL;DR: The goal of the Gene Ontology Consortium is to produce a dynamic, controlled vocabulary that can be applied to all eukaryotes even as knowledge of gene and protein roles in cells is accumulating and changing.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Therese Sørlie,Charles M. Perou,Robert Tibshirani,Turid Aas,Stephanie Geisler,Hilde Johnsen,Trevor Hastie,Michael B. Eisen,Matt van de Rijn,Stefanie S. Jeffrey,T. Thorsen,Hanne Quist,John C. Matese,Patrick O. Brown,David Botstein,Per Eystein Lønning,Anne Lise Børresen-Dale +16 more
TL;DR: Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-positive groups.
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh,Michael B. Eisen,R. Eric Davis,Izidore S. Lossos,Andreas Rosenwald,Jennifer C. Boldrick,Hajeer Sabet,Truc Tran,Xin Yu,John Powell,Liming Yang,Gerald E. Marti,Troy Moore,James I. Hudson,Li-Sheng Lu,David B. Lewis,Robert Tibshirani,Gavin Sherlock,Wing C. Chan,Timothy C. Greiner,Dennis D. Weisenburger,James O. Armitage,Roger A. Warnke,Ronald Levy,Wyndham H. Wilson,M. R. Grever,John C. Byrd,David Botstein,Patrick O. Brown,Louis M. Staudt +29 more
TL;DR: It is shown that there is diversity in gene expression among the tumours of DLBCL patients, apparently reflecting the variation in tumour proliferation rate, host response and differentiation state of the tumour.
An automated method for finding molecular complexes in large protein interaction networks.
TL;DR: A novel graph theoretic clustering algorithm, "Molecular Complex Detection" (MCODE), that detects densely connected regions in large protein-protein interaction networks that may represent molecular complexes is described.
Gene expression correlates of clinical prostate cancer behavior.
Dinesh Singh,Phillip G. Febbo,Phillip G. Febbo,Kenneth N. Ross,Donald G. Jackson,Judith Manola,Christine Ladd,Pablo Tamayo,Andrew A. Renshaw,Anthony V. D'Amico,Jerome P. Richie,Eric S. Lander,Massimo Loda,Philip W. Kantoff,Todd R. Golub,William R. Sellers +15 more
TL;DR: The results support the notion that the clinical behavior of prostate cancer is linked to underlying gene expression differences that are detectable at the time of diagnosis.
2.7K